Mosquitoes test positive for West Nile virus on Long Island
The 14 positive mosquito samples were taken in Nesconset, Northport, Dix Hills, Melville, Lindenhurst, West Babylon, St. James, Rocky Point and Holtsville, Suffolk County Health Commissioner Dr. Gregson Pigott announced Monday.
The samples were collected on July 16.
To date, Suffolk has reported 15 mosquito samples testing positive for West Nile virus and four testing positive for Jamestown Canyon virus, Pigott said.
"Mosquito activity is picking up with the warmer weather and with it comes the risk of being exposed to West Nile virus," Pigott said. "While there is no cause for alarm, we advise residents to take precautions and cooperate with us in our efforts to reduce exposure to mosquito-borne diseases."
West Nile has also been detected in mosquitoes in New York City this year, as experts track a rise in cases nationwide. Suffolk did not report any human cases and neither did the city.
West Nile virus has been detected in Suffolk County every year since 1999, when it first appeared, the County Department of Health Services said. There were 21 confirmed cases in 2024 and five in 2023. Two people in New Jersey died from the virus last year.
The virus is transmitted to humans when they are bitten by an infected mosquito.
"Most people infected with West Nile virus will experience mild or no symptoms, but some can develop severe symptoms including high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, vision loss, numbness, and paralysis. The symptoms may last several weeks, and neurological effects may be permanent. Individuals, especially those 50 years or older or those with compromised immune systems, are urged to take precautions to avoid being bitten by mosquitoes," according to the county's health department.
Suffolk's health commissioner released these tips for preventing mosquito bites:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
10 hours ago
- New York Times
Corrections: Aug. 2, 2025
An article on Thursday about Canada's measles outbreak misstated which officials were urging the Alberta provincial leader to declare a public health emergency. They were public health experts, not provincial officials. An article on Friday about the powerful earthquake that struck off the coast of Russia's Kamchatka Peninsula early Wednesday misstated the energy difference between earthquake magnitudes. A magnitude 9 quake has about three times as much energy as magnitude 8.7, not 10 times as much. It has about twice as much energy as magnitude 8.8, not three times as much. A dance review on Thursday about Noche Flamenca's 'Legacy of Our Dreams' misstated the end date of the company's performances at the Joyce Theater. The show runs through Aug. 10, not this Sunday. Errors are corrected during the press run whenever possible, so some errors noted here may not have appeared in all editions. To contact the newsroom regarding correction requests, please email nytnews@ To share feedback, please visit Comments on opinion articles may be emailed to letters@ For newspaper delivery questions: 1-800-NYTIMES (1-800-698-4637) or email customercare@
Yahoo
11 hours ago
- Yahoo
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025
Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, July 30, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Wednesday, August 13, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update, including an overview of the Company's operations and continued growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's second quarter 2025 financial results. The webcast will be available at the investor relations section of the Company's website at Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "Lucid Diagnostics Business Update" to join. Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at About Lucid DiagnosticsLucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients. For more information, please visit and for more information about its parent company PAVmed, please visit View original content to download multimedia: SOURCE Lucid Diagnostics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 hours ago
- Yahoo
How one small clinic proves hepatitis C doesn't have to be an epidemic
Although it's been over a decade since game-changing curative drugs for hepatitis C were approved, progress has been slow and treatment remains out of reach for many. But one small clinic in Buffalo, New York, is proving that doesn't have to be the case. Hepatitis C is a silent epidemic in the U.S., affecting up to 4 million people, according to the Centers for Disease Control and Prevention. Many people don't know they have it. Left untreated, the disease can cause cirrhosis and liver cancer. With a model that's faster, more accessible and remarkably effective, La Bodega, a clinic at Erie County Medical Center, is curing patients at a staggering rate. One of those patients is Lindsey Groffenberg, who quit drugs and was cured of Hep C at La Bodega. "When you're coming out of addiction, and you're trying to recover, the last thing you want is to feel small," she told CBS News. "When I entered La Bodega, I asked them, 'So, when's the doctor gonna come in?' And he said, 'I am the doctor.'" That doctor was Dr. Tony Martinez. "One of our mottos is 'come one, come all,'" Martinez told CBS News. "It's a very safe, stigma-free space, you know, I think people feel that when they come here." Groffenberg now helps others navigate recovery. Success stories like hers have made the clinic a model program. La Bodega gets Hep C patients on treatment in a single visit, and has a track record of curing about 98% of its 7,000-plus patients. New FDA-approved testing machines help speed up treatment. The testing machines, Martinez explained, allow them to see a patient and in that same visit confirm their diagnosis and initiate their meds. As drug costs have dropped, access should have improved, yet so far, less than a third of Americans with Hep C have been treated. Success stories like La Bodega's have policymakers seeking a national plan to eliminate Hep C. In Washington, a bipartisan bill backed by Senators Bill Cassidy and Chris Van Hollen would invest federal funds into wiping out the disease. The average patient with Hep C can rack up as much as $46,000 a year in medical costs. Treating patients early could save the government an estimated $7 billion over a decade. "This is a monumental step forward for anybody who has Hep C — they'd get access to medications," Martinez. Arkansas officials reveal new details about Devil's Den murders of husband and wife Reporter's Notebook: Diane Arbus' photography legacy Exhibition of influential photographer Diane Arbus' work opens in New York
